Analysis & Commentary

Latin America Drug Policy Dialogue 2013 Maldonado, Uruguay

The ninth meeting of the Informal Dialogue on Drugs Policy in Latin America took place in Maldonado, Uruguay
The dialogue--a report of which is available here--encouraged open and honest discussion on the dilemmas of regulation of the marijuana market.

Uruguay as Drug Policy Pioneer

What will Uruguay’s bold move to legalize and regulate cannabis mean for Uruguay and for the rest of Latin America?
In this article, WOLA's John Walsh unpacks the regional implications of Uruguay's recent vote to create a legal, regulated marijuana market.

U.S. Senate Confirms ATF Director

B. Todd Jones’ confirmation should enable the ATF to more effectively carry out its mandate, including addressing cross-border gun trafficking.

Protests in Brazil: Digging Beneath the Surface

Brazil’s recent country-wide demonstrations protesting a broad range of political and social conditions are interesting for reasons that go well beyond the specific issues raised by the protesters.

Progress and Pitfalls in Colombia’s Sugar Fields

Labor Rights Remain a Dream Unrealized for Colombia’s Workers
While a recent court case is encouraging, the vast majority of Colombia's workers continue to see their rights trampled.

Drug Policy Organizations Express Support for Uruguayan Reform Initiative

New Legislation Would Permit a Legal, Regulated Marijuana Market
Members organizations of the International Drug Policy Consortium (IDPC), including WOLA, and other drug policy organizations, express their support for Uruguay's efforts to create a legal, regulated marijuana market.

Is a “surge” in National Guard troops an effective way to secure the border?

During a recent hearing on border security, Rep. Palazzo of Mississippi floated the idea of deploying members of the National Guard to secure the border. But have these types of “surges” along the border been successful?

The Drug Policy Debate in Latin America

In this article, WOLA Senior Fellow Coletta A. Youngers outlines the changing landscape of the drug policy debate in Latin America